KR890008148A - 새로운 세파로스포린 화합물 및 항균제 - Google Patents

새로운 세파로스포린 화합물 및 항균제 Download PDF

Info

Publication number
KR890008148A
KR890008148A KR1019880012096A KR880012096A KR890008148A KR 890008148 A KR890008148 A KR 890008148A KR 1019880012096 A KR1019880012096 A KR 1019880012096A KR 880012096 A KR880012096 A KR 880012096A KR 890008148 A KR890008148 A KR 890008148A
Authority
KR
South Korea
Prior art keywords
carbon atoms
lower alkyl
new
group
sepharoseporin
Prior art date
Application number
KR1019880012096A
Other languages
English (en)
Other versions
KR970005844B1 (ko
Inventor
카쓰요시 이와마스
켄지 사카가미
아쓰미쿠니오
다 타카시 요시
세이지 시바하라
타카시 쓰루오카
신이치 콘도
Original Assignee
사사이 아키라
메이지제과 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사사이 아키라, 메이지제과 주식회사 filed Critical 사사이 아키라
Publication of KR890008148A publication Critical patent/KR890008148A/ko
Application granted granted Critical
Publication of KR970005844B1 publication Critical patent/KR970005844B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

내용 없음

Description

새로운 세파로스포린 화합물 및 향균제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 다음식으로 나타낸 새로운 세파로스포린 화합물 및 그약리상 허용되는 염.
    위식에서 R1, R2는 같거나 다른 수소원자 또는 탄소수 1-5의 저급알킬기, R3는 탄소수 1-5의 저급알킬기로 할로겐 원자를 함유하며, 또는 알케닐기, 또는 탄소수 3-6의 시클로알킬메틸기, A는 수소원자 또는 구핵성화합물잔기이다.
  2. 다음식으로 나타낸 새로운 세파로스포린화합물 및 그약기상 허용되는 염을 유효성분으로 함유하는 항균제.
    위식에서 R1, R2는 같거나 다른 수소원자 또는 탄소수 1-5의 저급알킬기, R3는 탄소수 1-5의 저급알킬기로 할로겐 원자를 함유하며, 또는 알케닐기, 또는 탄소수 3-6의 시클로알킬메틸기, A는 수소원자 또는 구핵성 화합물잔기이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880012096A 1987-11-11 1988-09-19 새로운 세파로스포린 화합물 및 항균제 KR970005844B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP62284634A JPH0633281B2 (ja) 1987-11-11 1987-11-11 新規セファロスポリン化合物及び抗菌剤
JP???62-284634 1987-11-11
JP?62-284634 1987-11-11

Publications (2)

Publication Number Publication Date
KR890008148A true KR890008148A (ko) 1989-07-10
KR970005844B1 KR970005844B1 (ko) 1997-04-21

Family

ID=17681012

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880012096A KR970005844B1 (ko) 1987-11-11 1988-09-19 새로운 세파로스포린 화합물 및 항균제

Country Status (5)

Country Link
US (1) US4971961A (ko)
EP (1) EP0315997B1 (ko)
JP (1) JPH0633281B2 (ko)
KR (1) KR970005844B1 (ko)
DE (1) DE3889198T2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028601A (en) * 1987-04-30 1991-07-02 Meiji Saika Kaisha, Ltd. Cephalosporin compounds and antibacterial agents
JPH0248580A (ja) * 1988-08-10 1990-02-19 Meiji Seika Kaisha Ltd 新規セファロスポリン系化合物及び抗菌剤
WO1992002523A1 (en) * 1990-08-02 1992-02-20 Sankei Pharmaceutical Company Limited Novel cephalosporin compound
EP0544958A1 (en) * 1990-08-09 1993-06-09 Tanabe Seiyaku Co., Ltd. Cephalosporin compounds and processes for preparing the same
WO2001034579A1 (fr) * 1999-11-10 2001-05-17 Takeda Chemical Industries, Ltd. Derives d'acide alcoxyiminoalcanoique
US20110118462A1 (en) * 2009-11-18 2011-05-19 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Factory N-heterocyclic substituent-containing antibiotic, preparation and use thereof
KR101716985B1 (ko) * 2015-12-24 2017-03-16 현대다이모스(주) 차량용 시트레일 록킹장치
CN110655526A (zh) * 2018-06-28 2020-01-07 中国科学院上海药物研究所 头孢菌素-铁载体轭合物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ215527A (en) * 1985-04-01 1989-06-28 Mochida Pharm Co Ltd Cephalosporin derivatives and pharmaceutical compositions
US4822786A (en) * 1986-07-01 1989-04-18 Kaken Pharmaceutical Co., Ltd. Cephalosporin compounds, and antibacterial agents
US5028601A (en) * 1987-04-30 1991-07-02 Meiji Saika Kaisha, Ltd. Cephalosporin compounds and antibacterial agents

Also Published As

Publication number Publication date
EP0315997A2 (en) 1989-05-17
JPH01125384A (ja) 1989-05-17
DE3889198T2 (de) 1994-11-24
EP0315997B1 (en) 1994-04-20
JPH0633281B2 (ja) 1994-05-02
DE3889198D1 (de) 1994-05-26
KR970005844B1 (ko) 1997-04-21
EP0315997A3 (en) 1990-11-28
US4971961A (en) 1990-11-20

Similar Documents

Publication Publication Date Title
KR950000728A (ko) 포스포네이트 뉴클레오티드 에스테르 유도체
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
KR900006296A (ko) 이미다졸린 유도체 및 그의 제조방법
KR960007592A (ko) 신규한 피롤로카바졸
KR930016402A (ko) 항-hiv 활성을 갖는 이미다졸 유도체
KR930703292A (ko) 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제
KR890008148A (ko) 새로운 세파로스포린 화합물 및 항균제
KR950702530A (ko) 프로스타글란딘 유도체
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR900003177A (ko) 테트라시클릭계 우울증 치료제
KR860003247A (ko) 티아디아진 화합물 및 그 염의 제조방법
KR960700245A (ko) 메토트렉세이트 유도체[methotrexate derivative]
KR850000455A (ko) 세팔로스포린 에스테르 유도체의 제조방법
KR890009901A (ko) 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용
KR900006316A (ko) 벤조 헤테로 고리화합물 및 그 제조방법
KR960703843A (ko) 아실페닐글리신 유도체 및 그 화합물을 유효성분으로 하는, 콜라게나제 활성증진에 기인한 질환의 예방 및 치료 제(acylphenylglycine derivative and preventive and remedy for diseases caused by increased collagenase activity containing said compound as active ingredient)
DK0420224T3 (da) Anthihepatopatisk middel
KR930702339A (ko) 에폭시숙시남산 유도체
KR850005228A (ko) 살균제인 아미노알칸포스폰산 및 그 유도체
KR890003718A (ko) N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제
FI853866A0 (fi) 2-pyridin-tiol-derivat, foerfarande foer framstaellning av dessa samt farmaceutiska foereningar innehaollande dessa.
DE3269533D1 (en) New quinolylacetic acid compounds and pharmaceutical compositions containing them
KR950000705A (ko) 14-치환 몰피난 유도체 및 이를 함유하는 의약
KR920008012A (ko) 트리아졸 유도체
KR840008012A (ko) 아미노에틸-피리딘 및 -피라진유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030414

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee